Literature DB >> 8070932

First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

R Almog1, C Block, M Gdalevich, B Lev, M Wiener, S Ashkenazi.   

Abstract

Outbreaks of meningococcal disease were observed for the first time in the Israel Defence Force (I.D.F.) in 1992 and 1993, while in previous years, cases appeared in sporadic fashion. Two episodes in the winter of 1992 involving three and two individuals, respectively, were caused by Neisseria meningitidis group C, which was nontypable and nonsubtypable (C:NT:-). Three cases in one event in early 1993 were due to group C:NT:P1.2, the two secondary cases being caused by strains completely resistant to rifampicin. While these outbreaks were small, they should be seen against a background of the emergence of relatively virulent clones of serogroup C which have caused significant outbreaks in several countries. This and the drug resistance problem will require medical decision-makers to review strategies for the prevention of meningococcal disease, taking into account alternative agents for chemoprophylaxis as well as a possible role for vaccination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070932     DOI: 10.1007/bf01739006

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Epidemiology of meningococcal disease in Denmark 1980-1988.

Authors:  S Samuelsson; S Gustavsen; T Rønne
Journal:  Scand J Infect Dis       Date:  1991

2.  Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis.

Authors:  F N Judson; J M Ehret
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

3.  Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.

Authors:  R G Masterton; E R Youngs; J C Wardle; K F Croft; D M Jones
Journal:  J Infect       Date:  1988-09       Impact factor: 6.072

4.  Influenza A and meningococcal disease.

Authors:  K A Cartwright; D M Jones; A J Smith; J M Stuart; E B Kaczmarski; S R Palmer
Journal:  Lancet       Date:  1991-08-31       Impact factor: 79.321

5.  Vaccination campaign against meningococcal disease in army recruits in Italy.

Authors:  T Stroffolini
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

6.  Risk factors for carriage of meningococcus in the Los Angeles County men's jail system.

Authors:  J C Thomas; N S Bendana; S H Waterman; M Rathbun; G Arakere; C E Frasch; J D Wenger; V Magsombol; J H Clark
Journal:  Am J Epidemiol       Date:  1991-02-01       Impact factor: 4.897

7.  A cluster of meningococcal disease on a school bus following epidemic influenza.

Authors:  L H Harrison; C W Armstrong; S R Jenkins; M W Harmon; G W Ajello; G B Miller; C V Broome
Journal:  Arch Intern Med       Date:  1991-05

8.  Forty years of meningococcal disease in Israel: 1951-1990.

Authors:  C Block; M Roitman; B Bogokowsky; S Meizlin; P E Slater
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

9.  Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.

Authors:  F E Ashton; J A Ryan; A Borczyk; D A Caugant; L Mancino; D Huang
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  Meningococcal disease and influenza-like syndrome: a new approach to an old question.

Authors:  B Hubert; L Watier; P Garnerin; S Richardson
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

View more
  9 in total

1.  Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, Brazil.

Authors:  Maria Cecília O Gorla; Ana Paula S de Lemos; Márcia Quaresma; Rita Vilasboas; Orgali Marques; Márcia U de Sá; Cinthya T Ogassavara; Maria Cristina de C Brandileone; Lee H Harrison; Juarez Dias
Journal:  Enferm Infecc Microbiol Clin       Date:  2011-11-09       Impact factor: 1.731

Review 2.  Bacterial meningitis: current controversies in approaches to treatment.

Authors:  A J Williams; S Nadel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Bacterial meningitis in children: critical review of current concepts.

Authors:  Ram Yogev; Judith Guzman-Cottrill
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers.

Authors:  L Arreaza; L de La Fuente; J A Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  Invasive meningococcal disease in children in Jerusalem.

Authors:  C Stein-Zamir; N Abramson; G Zentner; H Shoob; L Valinsky; C Block
Journal:  Epidemiol Infect       Date:  2007-07-30       Impact factor: 2.451

6.  Rifampin-resistant meningococcal disease.

Authors:  Jean Rainbow; Elizabeth Cebelinski; Joanne Bartkus; Anita Glennen; Dave Boxrud; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

7.  Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Authors:  Femke van Kessel; Caroline van den Ende; Anouk M Oordt-Speets; Moe H Kyaw
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

8.  Molecular characteristics of Neisseria meningitidis in Qatar.

Authors:  Manal Mahmoud Hamed; Fayaz Ahmad Mir; Emad Bashier Ibrahim Elmagboul; Abdullatif Al-Khal; Muna A Rahman S Al Maslamani; Anand Sarwottam Deshmukh; Hamad Eid Al-Romaihi; Mohd Ahmed M Sharif Janahi; Fatma Ben Abid; Adila Shaukat Ali Kashaf; Gulab Sher; Vinod Kumar Gupta; Godwin J Wilson; Junais Kadalayi; Sanjay H Doiphode
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

9.  EpiScanGIS: an online geographic surveillance system for meningococcal disease.

Authors:  Markus Reinhardt; Johannes Elias; Jürgen Albert; Matthias Frosch; Dag Harmsen; Ulrich Vogel
Journal:  Int J Health Geogr       Date:  2008-07-01       Impact factor: 3.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.